Roberto Aiolfi
Impact in
- Hepatology top 5%
- Hepatitis C virus research
- Hepatocellular Carcinoma Treatment and Prognosis
- Immunology top 10%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
Papers in ⓘ
-
- Hepatitis C virus research 4
- Hepatocellular Carcinoma Treatment and Prognosis 2
-
- COVID-19 Clinical Research Studies 4
- Viral Infections and Outbreaks Research 3
- Co-authors
- Giovanni Sitia (5 shared papers)Luca G. Guidotti (6 shared papers)Matteo Iannacone (5 shared papers)Francis V. Chisari (3 shared papers)Zaverio M. Ruggeri (6 shared papers)Amleto Fiocchi (3 shared papers)Pietro Di Lucia (2 shared papers)Marta Mainetti (2 shared papers)
- Journals
- Blood (4 papers)Journal of Thrombosis and Haemostasis (2 papers)Proceedings of the National Academy of Sciences (2 papers)PLoS Pathogens (1 paper)Science Signaling (1 paper)
- Partner nations
- United StatesItalyNetherlands
In The Last Decade
Roberto Aiolfi
14 papers receiving 693 citations
Peers
Comparison fields: 5 of 68
- Hepatology 264
- Immunology 252
- Epidemiology 281
- Hematology 64
- Oncology 156
Countries citing papers authored by Roberto Aiolfi
This map shows the geographic impact of Roberto Aiolfi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Aiolfi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Aiolfi more than expected).
Fields of papers citing papers by Roberto Aiolfi
This network shows the impact of papers produced by Roberto Aiolfi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Aiolfi. The network helps show where Roberto Aiolfi may publish in the future.
Co-authors
The 25 scholars most cited alongside Roberto Aiolfi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 260 | |
| 2 | 2015 | 239 | |
| 3 | 2011 | 92 | |
| 4 | 2018 | 29 | |
| 5 | 2016 | 26 | |
| 6 | 2015 | 25 | |
| 7 | 2015 | 13 | |
| 8 | 2024 | 3 | |
| 9 | 2014 | 3 | |
| 10 | 2022 | 3 | |
| 11 | 2022 | 2 | |
| 12 | Emerging role of dual antiplatelet therapy in the prevention of hepatitis B virus-associated hepatocellular carcinoma | 2014 | 1 |
| 13 | 2017 | 1 | |
| 14 | 2021 | 1 | |
| 15 | 2019 | 0 | |
| 16 | 2023 | 0 |
About Roberto Aiolfi
Roberto Aiolfi is a scholar working on Hepatology, Infectious Diseases, Immunology, Hematology and Epidemiology, having authored 16 papers that have together received 698 indexed citations. Recurring topics across this work include Hepatitis C virus research (4 papers), COVID-19 Clinical Research Studies (4 papers), Immunotherapy and Immune Responses (3 papers), Viral Infections and Outbreaks Research (3 papers), Liver Disease Diagnosis and Treatment (3 papers), Immune Cell Function and Interaction (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers) and Long-Term Effects of COVID-19 (2 papers). The work is most often cited by research in Hepatology (264 citations), Immunology (252 citations), Epidemiology (281 citations), Hematology (64 citations) and Oncology (156 citations). Roberto Aiolfi has collaborated with scholars based in United States, Italy and Netherlands. Frequent co-authors include Giovanni Sitia, Luca G. Guidotti, Matteo Iannacone, Francis V. Chisari, Zaverio M. Ruggeri, Amleto Fiocchi, Pietro Di Lucia, Marta Mainetti, Antonio Esposito and Francesca Mingozzi. Their work appears in journals such as Blood, Journal of Thrombosis and Haemostasis, Proceedings of the National Academy of Sciences, PLoS Pathogens and Science Signaling.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.